scholarly journals Comparison of serum acetyl hydrolase (PAF-AH) and paraoxonase 1 (PON1) values between prostate cancer patients and a control group

2017 ◽  
Vol 33 (11) ◽  
pp. 572-577
Author(s):  
Erdal Benli ◽  
Ahmet Bayrak ◽  
Abdullah Cirakoglu ◽  
Tulin Bayrak ◽  
Tevfik Noyan
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Paraoxonase 1 ◽  
Control Group

scholarly journals Enhanced recovery after surgery protocol for prostate cancer patients undergoing laparoscopic radical prostatectomy

2018 ◽  
Vol 47 (1) ◽  
pp. 114-121 ◽  
Author(s):  
Chunhua Lin ◽  
Fengchun Wan ◽  
Youyi Lu ◽  
Guojun Li ◽  
Luxin Yu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Radical Prostatectomy ◽  
Cancer Patients ◽  
Enhanced Recovery ◽  
Enhanced Recovery After Surgery ◽  
The Body ◽  
Laparoscopic Radical Prostatectomy ◽  
Control Group ◽  
Tube Removal ◽  
Hospitalization Costs

Objective To determine the value of an enhanced recovery after surgery (ERAS) protocol for prostate cancer patients undergoing laparoscopic radical prostatectomy (LRP). Methods We conducted a retrospective cohort study using clinical data for 288 patients who underwent LRP in our hospital from June 2010 to December 2016. A total of 124 patients underwent ERAS (ERAS group) and the remaining 164 patients were allocated to the control group. ERAS comprised prehabilitation exercise, carbohydrate fluid loading, targeted intraoperative fluid resuscitation and keeping the body warm, avoiding drain use, early mobilization, and early postoperative drinking and eating. Results The times from LRP to first water intake, first ambulation, first anal exhaust, first defecation, pelvic drainage-tube removal, and length of hospital stay (LOS) were all significantly shorter, and hospitalization costs and the incidence of postoperative complications were significantly lower in the ERAS group compared with the control group. No deaths or reoperations occurred in either group, and there were no readmissions in the ERAS group, within 90 days after surgery. Conclusion ERAS protocols may effectively accelerate patient rehabilitation and reduce LOS and hospitalization costs in patients undergoing LRP.

Radiation Proctitis: The Potential Role of Hyaluronic Acid in the Prevention and Restoration of Any Damage to the Rectal Mucosa among Prostate Cancer Patients Submitted to Curative External Beam Radiotherapy

2021 ◽  
Vol 12 (4) ◽  
pp. 446-455
Author(s):  
Gianluca Ferini ◽  
Antonella Tripoli ◽  
Vincenza Umina ◽  
Giuseppina Rita Borzì ◽  
Valentina Anna Marchese ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Hyaluronic Acid ◽  
Cancer Patients ◽  
Radiation Proctitis ◽  
Dose Fractionation ◽  
Control Group ◽  
Consecutive Series ◽  
Median Dose ◽  
Significant Difference ◽  
Experimental Group

Aim: To evaluate if hyaluronic acid reduces proctitis episodes with respect to corticosteroids in prostate cancer patients submitted to radical or adjuvant radiotherapy. Methods: A consecutive series of eligible patients received hyaluronic acid enemas as supportive care (experimental group, from January 2013 to June 2015). A historical group (control group), treated from October 2011 to December 2012, received beclomethasone dipropionate suppositories. We registered each patient’s data regarding acute and chronic proctitis. All patients were treated with static-intensity-modulated radiotherapy coupled to a daily set-up verification with orthogonal anterior–posterior/lateral X-ray pairs. Results: A total of 269 patients, 175 in the experimental group and 94 in the control group, was evaluated; 2 Gy/day (up to a total median dose of 80 Gy) and 2.7 Gy/day (up to a total median dose of 67.5 Gy) fractionation schemes were used for 216 and 53 patients, respectively. All patients had a good tolerance to radiotherapy, reporting no G3 or greater proctitis. No significant difference was reported concerning the total rate of proctitis between the two groups but only with respect to its grade: a higher G2 rate within the control group. There was no correlation between daily dose fractionation and toxicity grade. Conclusions: Hyaluronic acid enemas might be effective in reducing the severity of radiation proctitis.

scholarly journals Does regular physical exercises during radiotherapy influence on fatigue, and physical endurance in high-risk prostate cancer patients?

2020 ◽  
Vol 23 (4) ◽  
pp. 21-27
Author(s):  
Katarzyna Hojan ◽  
Piotr Milecki
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Physical Exercise ◽  
Cancer Patients ◽  
Functional Capacity ◽  
Psychological Status ◽  
Moderate Intensity ◽  
Control Group ◽  
Controlled Clinical Trial ◽  
Physical Endurance

Background. During radiotherapy (RT), prostate cancer (PCa) patients very often report fatigue, which impairs functional capacity, psychological status, and quality of life (QoL). It is well known that physical exercise plays an important role in healthy adults, has positive role for immunological aspects and improves QoL in cancer patients. Previous studies have shown that physical exercise in cancer patients undergoing RT improves cardiac fitness, and QoL, however it is still not well known how physical exercise affects physical fitness and fatigue in PCa patients during RT. Therefore, the purpose of this study was to examine the effect of supervised physical exercise on the relationship between fatigue and physical endurance in high-risk PCa patients undergoing RT. Material and Methods This was a prospective, two-arm randomised controlled clinical trial. The study was performed in outpatients in the Greater Poland Cancer Centre. Population. Seventy-two high-risk PCa men were randomly allocated to two groups prior to undergoing RT. Thirty-six patients performed supervised moderate-intensity physical exercise (exercise group; EG) and the other 36 formed a control group that carried out normal daily physical activity (usual group; UG). The following parameters were assessed before and after RT: functional capacity, fatigue scores. Results. No significant differences existed between the study groups at pre-RT assessment. After RT, there was a significant improvement in functional capacity (p<0.05) and important smaller fatigue scores in EG. Conclusion. Regular, moderate-intensity physical exercise improves functional capacity and has positive influence on fatigue symptoms during RT in high-risk PCa patients. Therefore, this group of patients should conduct regular physical training during RT to decrease side effects of treatment.

scholarly journals Evaluation of Neutrophil, Lymphocyte, Platelet, Mean Platelet Volume, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio in Prostate Cancer Patients Treated with Radiotherapy

2020 ◽  
Vol 7 (5) ◽  
pp. 482-488 ◽  
Author(s):  
Nurten Bahtiyar ◽  
Özlem Mermut
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Mean Platelet Volume ◽  
Venous Blood ◽  
Control Group ◽  
Platelet Volume ◽  
Neutrophil Lymphocyte Ratio ◽  
Lymphocyte Ratio ◽  
Radiotherapy Group ◽  
Platelet Lymphocyte Ratio

Objective: Radiotherapy is a one cura­tive method for prostate cancer. Ionizing radiation can cause inflammation of tissues in and around the irradiated sites. But it is also suggested that low-dose radiation has anti-inflammatory effects. The present study was aimed at investigating the effects of radiotherapy on some inflammatory markers in prostate cancer patients. Material and Methods: A total of 42 patients with prostate cancer and 30 healthy subjects were included in the present study. The day prior to radiotherapy (pre radiotherapy group) and the day radiotherapy was completed (post radiotherapy group) venous blood samples were collected. Neutrophil, lymphocyte, platelet, mean platelet volume (MPV), neutrophil-lymphocyte ratio (NLR), and platelet-lymphocyte ratio (PLR) levels were detected. Results: Neutrophil values of the pre radiotherapy group were higher than the control group (p<0.05), and values of the post radiotherapy group were lower than the pre radiotherapy group (p<0.001). Lymphocyte values of the post radiotherapy group were lower than the control, and the pre radiotherapy groups (p <0.001 for both). Platelet values were decreased in the post radiotherapy group compared to the pre radiotherapy group (p <0.01). MPV values of the pre radiotherapy group were higher than the control group (p<0.05), and were lower in the post radiotherapy group than the pre radiotherapy group (p <0.001). NLR and PLR values were decreased in the post radiotherapy group compared to the control group (p <0.001 for both), and were increased in post radiotherapy group compared to the pre radiotherapy group (p<0.001 for both). Conclusion: Our findings showed that neutrophil, and MPV were increased in the pre radiotherapy group compared to the control group. Neutrophil, lymphocyte, platelet, and MPV were decreased, NLR and PLR were increased in the post radiotherapy group compared to the pre radiotherapy group.

scholarly journals IL-18 Gene Polymorphisms Impacts on Its Serum Levels in Prostate Cancer Iraqi Patients

2019 ◽  
pp. 1188-1196
Author(s):  
Mahmmod Talib Shkaaer ◽  
Nawal Mohammed Utba
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Gene Promoter ◽  
Serum Levels ◽  
Control Group ◽  
Arab Population ◽  
Prostate Cancer Development ◽  
Age Range ◽  
And Control ◽  
Il18 Gene

Prostate cancer is one of the most common types of cancer in men. A total of 110 Iraqi Arab individuals were included in this study; 60 individuals of them had prostate cancer with increased levels of TPSA (patients group); their age range 52-90 years. They were referred for diagnosis and treatment to the National Al-Amal Hospital for oncology in Baghdad during the period from July 2017 to October 2017. While the other 50 apparently healthy subjects were the control group, their age range similar to patients group. Sera and blood samples were collected from all patients and controls than used to assess for the level of IL-18 and DNA extraction, respectively. The polymorphisms were analyzed using polymerase chain reaction-single specific primer (PCR-SSP), at the position -137 G\C (rs187238) in the promoter of IL18 gene. The genetic polymorphism of the IL18 gene promoter -137G/C (rs187238) was determined and presented with three genotypes (GG, GC, and CC) in prostate cancer patients and controls. Testing for Hardy-Weinberg (H-W) equilibrium revealed that Prostate cancer patients showed insignificant variation in the distribution of IL-18 -137 genotypes (P> 0.05). While the control samples showed significant variation (p ≤0.05) between the observed and expected. Comparing patients with controls indicated that IL-18-137 alleles or genotypes showed no association with the risk of prostate cancer development in Iraqi Arab population or protection against them. Serum level of IL-18 was highly significant (P ≤ 0.001) increased in patients compared to control. The IL-18 serum levels differences in GG and GC genotypes was significant (p <0.05) between patients and control. While there were no significant differences between the three IL-18 -137 genotypes inpatient or in controls.

scholarly journals Psychosocial Intervention In Prostate Cancer Patients

2015 ◽  
Vol 55 (1) ◽  
pp. 1-10
Author(s):  
Jana Potočníková ◽  
Tomáš Gregor ◽  
Helena Medeková ◽  
Aurel Zelko
Keyword(s):  
Prostate Cancer ◽  
Training Program ◽  
Cancer Patients ◽  
Standardized Tests ◽  
Autogenic Training ◽  
Control Group ◽  
Depression Symptoms ◽  
Common Cancer ◽  
And Control

Summary Prostate cancer is the second most common cancer worldwide for males, and the fifth most common cancer overall. Using of autogenic training could reduce the influence of ADT and raise quality of prostate cancer patients. The aim of this study was to determine the effects of autogenic training in patients with prostate cancer. Patients were divided to experimental and control group. Experimental group participated in fourteen weeks long autogenic training program. Control group performed usual daily activities. Every subject of research performed input and output diagnostics which monitored psychical states of patients by psychological standardized tests - Differential questionnaire of depression (DDF) and Questionnaire of anxiety (STAI X1). Our data showed autogenic training program significant improved depressions symptoms and anxiety in experimental research group (p ≤ 0.05), however there was no main change of depression symptoms and anxiety values for control group (p = n.s.).

A phase II report of longitudinal bone marker time trends in racially diverse prostate cancer patients receiving zoledronic acid with androgen deprivation

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 14568-14568
Author(s):  
V. R. Phooshkooru ◽  
H. J. Spencer ◽  
M. Kohli
Keyword(s):  
Prostate Cancer ◽  
Vitamin D ◽  
Zoledronic Acid ◽  
Bone Turnover ◽  
Cancer Patients ◽  
Androgen Deprivation ◽  
Control Group ◽  
Turnover Rates ◽  
Mineral Density ◽  
Racially Diverse

14568 Background: Evidence for preventing androgen deprivation (AD) induced osteoporosis with bisphosphonate therapy in prostate cancer patients has emerged largely from trials conducted in caucasian patients. Osteoporosis related skeletal event incidence in African Americans (AA) receiving AD is significantly lower than caucasians and the effect of bisphosphonates therapy uncertain. We conducted a prospective study to evaluate the efficacy of zoledronic acid in preventing osteoporosis in racially diverse population receiving AD. Methods: Asymptomatic, prostate cancer patients (16 caucasians and 6 AA) with normal renal function undergoing AD, started within the last 9 months were randomized to receive (Arm A) CaCO3/vitamin D (500 mg/200U TID) or (Arm B) CaCO3/vitamin D and zoledronic acid (4 mg IV every 3 months for a year). Bone turnover markers including urine N-telopeptide, serum osteocalcin, serum bone specific alkaline phosphatase(BsAP) were serially measured every 3 months and bone mineral density (BMD) measured by DXA at hip, femur, spine and ward’s triangle at 0, 6 and 15 month intervals. Primary endpoint was to obtain BMD changes and bone turnover rates for each treatment arm. Nonparametric methods for analyzing longitudinal data were used to compare DXA-derived BMD measures and bone turnover rate markers in patients receiving zoledronic acid to the control group. Results: Data is presented for 16/22 patients who have completed 15- month follow up. Time trend analysis of bone formation (BsAP, osteocalcin) and resorption (N-telopeptide) markers and DXA measurements of BMD (spine and hip) are shown in the table. Conclusions: This study suggests that zoledronic acid preserves BMD at spine in racially diverse patients and, likewise provides preliminary estimates of BMD changes that occur over 15 months in patients receiving zoledronic acid and placebo. Larger AA cohorts are needed for prospective validation of the observed effect with zoledronic acid. [Table: see text] [Table: see text]

In vivo isolation of circulating tumor cells in prostate cancer patients by a medical device.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e22055-e22055
Author(s):  
Gerit Theil ◽  
M.Raschid Hoda ◽  
Kersten Fischer ◽  
Andre Schumann ◽  
Kathrin Haubold ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Medical Device ◽  
Molecular Genetic ◽  
Control Group ◽  
Detection Rates ◽  
Benign Prostate Hypertrophy ◽  
Multiple Metastases ◽  
Crucial Information

e22055 Background: CTCs are discussed as a prognostic and stratification biomarker, and may help to assess the treatment efficacy. The aim was to demonstrate proof of concept of in vivo CTC isolation in Prostate cancer patients (PCa). Methods: A medical device (CellCollector) was inserted in a cubital vein for 30 minutes. The interaction of target CTCs with the CellCollector was mediated by antibodies to the epithelial cell adhesion molecule (EpCAM). To confirm binding of CTCs to the wire, immunohistochemical staining against Cytokeratin and CD45 was performed. There were 226 applications of the device in 16 metastasized PCa (PCa-m) with up to 8 wire applications per patient, 24 localized PCa (PCa-l) with up to 3 wire applications per patient as well as 19 men with benign prostate hypertrophy (BPH) and 21 women as control group with only one wire application. CTC counts from 22 PCa patients with 58 applications were directly compared to the CellSearch technology. Results: We obtained in vivo isolation of CTCs in 73 of 98 applications to PCa patients (74.5 %). The sensitivity for metastasized PCa was (86.2%) and for local PCa (57.5%), respectively. Follow up data of one patient with PCa-m: 2009 diagnosed PCa with multiple metastases. 2 years later PSA of 11.2ng/mL and 25 CTCs. After transurethral resection and removal of a brain metastasis, CTCs decreased to 20 cells with no effect on PSA levels. 4 months later we observed 187 CTCs and a PSA level of 76ng/mL, which was correlated with the patient condition. In PCa-l patients we observed prior radical prostatectomy (n=18) and 6 (n=15) and 12 (n=7) months after surgery CTC numbers on average of 18.2, 2.8 and 1.4, respectively. In the direct comparison of the CellCollector and CellSearch we showed detection rates of 65% (13/20) and 20% (4/20). Conclusions: We demonstrate the use of CTCs besides PSA during therapy adjustment in PCa patients In summary the CTC detection rate of the CellCollector in PCa-m and PCa-l in comparison to the CellSearch method increased by 26% and 45%. Further molecular genetic CTC characterization as well as multiple antibody coating at the CellCollector will assume crucial information for therapy decisions. Clinical trial information: ISRCTN10403616.

scholarly journals Risk Factors for Prostate Cancer Patients Among Gezira State-Central of Sudan

1970 ◽  
Vol 12 (4) ◽  
Author(s):  
Fatima A Hamad ◽  
And D. O. Abuidris
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Family History ◽  
Cancer Patients ◽  
The Body ◽  
Control Group ◽  
Education Levels ◽  
Male Patients ◽  
The Mean ◽  
Disease Family

The aim of this study is to assess the risk factors for prostate cancer among Sudanese patients treated in National Cancer Institute (NCI), Gezira University, Wadmedani, Sudan. The study was performed on 268 prostate cancer patients, age ranging between 45-98 years. Similar number of 268 persons (age and sex matched) was used as control group .The study period was from May-2006 to December-2009. Data was collected from patients using a questionnaire which was filled in order to obtain information regarding: age, residence, tribe, education levels, occupation, marital status, stage of disease, family history and habits .The body mass index (BMI) was determined by anthropometrics measurements ( weight& height). Prostate cancer is the commonest cancer among male patients treated in the NCI. The mean age of patients was 72.2±9.25. Most of patients (73.9%) were over 66-years. Family history is positive in 18(6.7%) of the patients. Rural inhabitants were 79.8% of all cases. The disease is equally distributed among different tribes. The illiteracy among cases is 39.1%. The commonest occupation was farming (60.1%). Majority (90.7%) of the patients were married. Most cases (85.4%) presented with stage ІІІ and ІV. 73% of the patients had one or more of unhealthy habits (smoking, snuff and alcohol). the BMI was high in 6.9% of the patients. Risk factors for prostate cancer in the study area, which may appear to have a high significant effect, were: the age, education level, occupation, unhealthy habits and the BMI. ABSTRAK: Tujuan kajian ini dijalankan ialah untuk menilai faktor-faktor risiko untuk kanser prostat di kalangan pesakit-pesakit yang dirawat di Institut Kanser Kebangsaan (NCI), Universiti Gezira, Wadmedani, Sudan. Kajian dijalankan pada 268 pesakit kanser prostat, berumur di antara 45-98 tahun. Jumlah bilangan pesakit yang sama iaitu seramai 268 orang (sama umur dan jantina) telah digunakan sebagai kumpulan kawalan.Tempoh kajian ialah pada Mei 2006 sehingga Disember 2009. Data diperolehi daripada pesakit-pesakit dengan menggunakan boring soal selidik yang diisi untuk mendapatkan maklumat: umur, tempat tinggal, puak, taraf pendidikan, pekerjaan, status perkahwinan, peringkat penyakit, sejarah keluarga dan tabiat-tabiat. Indeks jisim badan (BMI) telah ditentukan melalui pengukuran antropometri (berat dan ketinggian). Kanser prostat ialah kanser yang paling banyak dihidapi pesakit-pesakit yang dirawat di NCI. Purata umur ialah 72.2±9.25. Kebanyakan pesakit (73.9%) berumurlebih 66 tahun. Sejarah keluarga ialah positif pada 18 (6.7%) pesakit. Penduduk luar bandar ialah 79.8% daripada keseluruhan jumlah kes. Penyakit ini terbahagi sama rata di antara puak-puak. Kadar buta huruf di antara kes-kes ialah 39.1%. Pekerjaan yang paling banyak ialah bertani (60.1%). Majoriti (90.7%) pesakit telah berkahwin. Kebanyakan kes-kes (85.4%) menghidapi peringkat III dan IV penyakit. 73% daripada jumlah pesakit mempunyai satu atau lebih tabiat yang kurang sihat (merokok, menghidu, dan alkohol). 6.9% pesakit mempunyai indeks jisim badan (BMI) yang tinggi. Faktor-faktor risiko untuk kanser prostat di dalam kawasan kajian yang menunjukkan kesan signifikan yang tinggi ialah: umur, taraf pendidikan, pekerjaan, tabiat-tabiat kurang sihat dan indeks jisim badan (BMI).

Sign in / Sign up

Export Citation Format

Share Document